Skip to content
Home/Companies/Biotech/Sorriso Pharmaceuticals

Sorriso Pharmaceuticals

Biotech·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Sorriso Pharmaceuticals?

Sorriso Pharmaceuticals is currently owned by Lundbeckfonden BioCapital through Lundbeckfonden BioCapital (2009 vintage), since 2021.

Hand-verified · updated 2026-08-18

Lundbeckfonden BioCapital
Investor
Lundbeckfonden BioCapital
Lundbeckfonden BioCapital · 2009 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Lundbeckfonden BioCapital

Other portfolio companies in the same fund.

QuantumCell
Active
BiotechDenmark· 2025
Kvantify
Active
Deep TechDenmark· 2024
Dania Therapeutics
Active
BiotechDenmark· 2023
Epoqe Pharma
Active
BiotechDenmark· 2021
Lexeo Therapeutics
Exited 2023
BiotechUS· 2021
Notify Therapeutics
Active
BiotechDenmark· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Sorriso Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sorriso Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sorriso Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue